Nektar Therapeutics (NASDAQ:NKTR)
| 23.53 Delayed Data As of Feb 21 |  -0.14 / -0.59%Today’s Change | 15.64 Today|||52-Week Range 42.92 | +9.01% Year-to-Date |
Latest NKTR News | Press Releases
No recent news for Nektar Therapeutics.
Today’s Trading
| Previous close | 23.67 |
| Today’s open | 23.49 |
| Day’s range | 23.21 - 23.89 |
| Volume | 1,228,849 |
| Average volume (3 months) | 2,502,120 |
| Market cap | $4.1B |
Data as of 4:00pm ET, 02/21/2020
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -166.64% |
| Earnings growth (next 5 years) | -7.38% |
| Revenue growth (last year) | +287.81% |
| P/E ratio | NM |
| Price/Sales | 4.96 |
| Price/Book | 2.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MORMorphoSys AG | +0.16 | +0.52% |
| ARWRArrowhead Pharmaceut... | -1.25 | -3.15% |
| MNTAMomenta Pharmaceutic... | -0.16 | -0.47% |
| ---- |
Data as of 4:00pm ET, 02/21/2020
Financials
| Next reporting date | February 25, 2020 |
| EPS forecast (this quarter) | -$0.68 |
| Annual revenue (last year) | $1.2B |
| Annual profit (last year) | $681.3M |
| Net profit margin | 57.09% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
